Kurz gefasst
Fachartikel in der Zeitschrift Science, 2023. Verfasst von Jocelyn Kaiser. Hauptthemen laut MEDLINE: Cholesterol, LDL, CRISPR-Cas Systems, Gene Editing, Genetic Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Verve Therapeutics says its base-editing approach may help prevent heart disease in many people
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Cholesterol, LDLCRISPR-Cas SystemsGene EditingGenetic TherapyHyperaldosteronismProprotein Convertase 9HumansBase PairingDNAClinical Trials as Topic
Substanzen
Cholesterol, LDLDNAPCSK9 protein, humanProprotein Convertase 9
Zitieren
APA
Kaiser, J. (2023). Rewriting DNA in the body lowers cholesterol. Science. https://doi.org/10.1126/science.adm9506
Vancouver
Kaiser J. Rewriting DNA in the body lowers cholesterol. Science. 2023. doi:10.1126/science.adm9506
BibTeX
@article{Kaiser2023,
author = {Kaiser, Jocelyn},
title = {Rewriting DNA in the body lowers cholesterol},
journal = {Science},
year = {2023},
doi = {10.1126/science.adm9506}
}
EUVIMED